Potent knockdown of the X RNA of hepatitis B by a novel chimeric siRNA-ribozyme construct and modulation of intracellular target RNA by selectively disabled mutants

Oligonucleotides
Nidhi GuptaA C Banerjea

Abstract

A multitarget approach is needed for effective gene silencing that combines more than one antiviral strategy. With this in mind, we designed a wild-type (wt) and selectively disabled chimeric mutant (mt) constructs that consisted of small hairpin siRNA joined by a short intracellular cleavable linker to a known hammerhead ribozyme, both targeted against the full-length X RNA of hepatitis B. These chimeric RNAs possessed the ability to cleave the target RNA under in vitro conditions and were efficiently processed at the cleavable site. When this wt chimeric RNA construct was introduced into a liver-specific mammalian cell line, HepG2, along with the HBx substrate encoding DNA, very significant (approximately 70%) intracellular downregulation in the levels of target RNA was observed. When the siRNA portion of this chimeric construct was mutated, keeping the ribozyme (Rz) region unchanged, it caused only approximately 25% intracellular reduction. On the contrary, when only the Rz was made catalytically inactive, about 55% reduction in the target RNA was observed. Construct possessing mt Rz and mt siRNA caused only 10% reduction. This wt chimeric construct also resulted in almost complete knockdown of intracellular HBx protein prod...Continue Reading

References

May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·V KumarR Kumar
May 20, 1999·Nature Biotechnology·M J CairnsL Q Sun
Feb 15, 2001·The Biochemical Journal·R Goila, A C Banerjea
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·S ShahiA C Banerjea
May 10, 2002·Nucleic Acids Research·Olivier Donzé, Didier Picard
Jul 9, 2002·Biochemical and Biophysical Research Communications·Marianne Leirdal, Mouldy Sioud
Apr 16, 2003·European Journal of Biochemistry·Jens Kurreck
Apr 20, 2004·BioTechniques·Lisa Scherer, John J Rossi
May 12, 2004·Journal of Molecular Biology·Steffen SchubertJens Kurreck
Jun 11, 2004·Annual Review of Biochemistry·Gerald F Joyce
Apr 6, 2006·Handbook of Experimental Pharmacology·S Schubert, J Kurreck
Apr 25, 2006·BioTechniques·John J Rossi
May 25, 2006·Frontiers in Bioscience : a Journal and Virtual Library·Ali RamezaniSadhna Joshi
May 5, 2007·Annual Review of Genomics and Human Genetics·Scott E Martin, Natasha J Caplen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.